Treatment of Sleep Disorders with Neurofeedback

The study of neurofeedback effect on broken sleep, duration of sleep, restless leg syndrome changes and improvement of the quality of life HIV patients with sleep disorders.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190620043954N1

Enrollment

Registered

2020-10-20

Start date

2018-10-29

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disorders. Sleep disorders

Interventions

Intervention 1: Intervention group: 12 sessions of Neurofeedback treatment (20 minute,3 times a week). Intervention 2: Control group: The control group does not receive the intervention and receiv

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Having at least 18 years and maximum 50 years Ability to read and write Lack of psychotic disorders based on clinical interviews No use of hypnotic drugs A change of dose and the type of psychiatric medications of two months before entering the project until to end of the follow up period Not having history of Seizure Diagnostics one type of sleep disorders according to interviews and questionnaire

Exclusion criteria

Exclusion criteria: Lack of desire to continue treatment Treatmenting ECT fromentering of the project to follow up period To use of hypnotic drugs from entering of the project to end of follow up period Having seizures from entering of the project to follow up period Exacerbation of symptoms of HIV that they may not continue to the project

Design outcomes

Primary

Measure	Time frame
Measurement of sleep quality. Timepoint: Before the onset of treatment and two weeks after starting treatment. Method of measurement: Pittsburgh Sleep Quality Index.	—

Secondary

Measure	Time frame
Improvement of sleep quality. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: Polysomnography.;Interrupted sleep. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: Polysomnography.;Time to fall asleep. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: Polysomnography.;Restless leg syndrome. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: Polysomnography.;Improving the quality of life. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: HIV/AIDS – Quality of Life (HAT-QoL) questionnaire.	—

Measure

Time frame

Improvement of sleep quality. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: Polysomnography.;Interrupted sleep. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: Polysomnography.;Time to fall asleep. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: Polysomnography.;Restless leg syndrome. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: Polysomnography.;Improving the quality of life. Timepoint: Early (before the onset of treatment)and the end of the study (after the end of treatment). Method of measurement: HIV/AIDS – Quality of Life (HAT-QoL) questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Salehi

Tehran University of Medical Sciences

salehi-m@razi.tums.ac.ir+98 21 6658 1583

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026